Bill117th CongressFiled Mar 7, 2022Health
H.R. 6963
Accelerated Approval Integrity Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 7, 2022)
Accelerated Approval Integrity Act of 2022
This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.
What just happenedMar 8, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Pallone, Frank, Jr. [D-NJ-6](D-NJ)Sponsor
1 cosponsor1 D
1cosponsors1committees4actions
- Introduced in HouseMar 7, 2022
- Mar 8, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 7, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 7, 2022IntroReferralIntro-H
Introduced in House
- Mar 7, 2022IntroReferral1000
Introduced in House